The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant tislelizumab combined with capecitabine for patients with biliary tract cancer with high risk of postoperative relapse (ACTIVE): Primary analysis from a prospective cohort study.
 
Luyu Yang
No Relationships to Disclose
 
Lu Lu
No Relationships to Disclose
 
Xiangyu Wang
No Relationships to Disclose
 
Haoting Sun
No Relationships to Disclose
 
Ying Zhu
No Relationships to Disclose
 
Da Xu
No Relationships to Disclose
 
Jimeng Yang
No Relationships to Disclose
 
Baobing Yin
No Relationships to Disclose
 
Xin Yang
No Relationships to Disclose
 
Wenwei Zhu
No Relationships to Disclose
 
Huliang Jia
No Relationships to Disclose
 
Jinhong Chen
No Relationships to Disclose
 
Lunxiu Qin
No Relationships to Disclose